NXS 2.33% 21.0¢ next science limited

Ann: Appendix 4C & Quarterly Activity Report - 31 December 2023, page-10

  1. 221 Posts.
    lightbulb Created with Sketch. 122
    When you are growing at 80% compound per annum and adding new customers daily, to expect your quarterly cashflow from sales to equal your quarterly revenue is just silly. I doubt they have many customers who are on a cash only basis. Most of their customers would have negotiated at least 30 days and probably more to pay their accounts. A fair few of their customers are huge hospital groups or medical conglomerates. As a consequence, there will always be a lag between a sale and receipt of cash and in a business growing like the clappers, this is even more pronounced.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.